Skip to content
RDL Network logo
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial — Paul Moayyedi (2019) | RDL Network